Clinical trial
Comparison of Ultrasound-Guided Intertransverse Process Block Versus Erector Spinae Plane Block for Postoperative Analgesia After Percutaneous Nephrolithotomy: A Prospective, Stratified Block-Randomised, Triple-Blind, Superiority Trial
NCT07908992 is registered in ClinicalTrials.gov with Beijing Tsinghua Chang Gung Hospital as lead sponsor.
Follow this trial by email Email me the PDF
Summary
Not yet recruiting, started December 2026. Interventional study, 140 participants (estimated). Lead sponsor Beijing Tsinghua Chang Gung Hospital; China. Primary measure: Cumulative opioid consumption within 48 hours after surgery, expressed as oral morphine equivalents (OME). 3 linked papers (newest 2016).
How it compares
306 similar trials: same condition (Kidney Calculi) and phase
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of Ultrasound-Guided Intertransverse Process Block Versus Erector Spinae Plane Block for Postoperative Analgesia After Percutaneous Nephrolithotomy: A Prospective, Stratified Block-Randomised, Triple-Blind, Superiority Trial
- Lead sponsor
- Beijing Tsinghua Chang Gung Hospital
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- December 31, 2026
- Completion date
- June 30, 2028
- Enrollment
- 140 (estimated)
- Sites
- 1
Conditions
MeSH condition names; the registry's own terms follow.
Kidney Calculi, Postoperative Pain, Urolithiasis
Registry terms: kidney stones, urolithiasis, hypocitraturia, pain, postoperative
Who could take part, where it ran, who ran it
As filed in ClinicalTrials.gov.
- Sex
- All
- Minimum age
- 18 Years
- Healthy volunteers
- No
- Study type
- Interventional
- Sites
- 1
- Countries
- China
- Lead sponsor
- Beijing Tsinghua Chang Gung Hospital
Arms
As registered; 2 arms.
| Arm | Type | Interventions |
|---|---|---|
| Intertransverse process block (ITPB) | Experimental | Ultrasound-guided intertransverse process block |
Show registry wordingParticipants allocated to this arm receive a single-shot ultrasound-guided intertransverse process block at the T10-T11 level with 20 mL of 0.375% ropivacaine, performed after induction of general anaesthesia and before surgical positioning. All participants receive identical standardised general anaesthesia, patient-controlled intravenous analgesia with sufentanil and rescue analgesia with intravenous flurbiprofen. | ||
| Erector spinae plane block (ESPB) | Active comparator | Ultrasound-guided erector spinae plane block |
Show registry wordingParticipants allocated to this arm receive a single-shot ultrasound-guided erector spinae plane block at the T10-T11 level with 20 mL of 0.375% ropivacaine, performed after induction of general anaesthesia and before surgical positioning. All participants receive identical standardised general anaesthesia, patient-controlled intravenous analgesia with sufentanil and rescue analgesia with intravenous flurbiprofen. | ||
Primary endpoints
Registered primary outcome measures; 1 primary.
| Measure | Time frame |
|---|---|
| Cumulative opioid consumption within 48 hours after surgery, expressed as oral morphine equivalents (OME) | From the end of surgery to 48 hours after surgery |
Show registry wordingCumulative amount of opioid consumed from the end of surgery through 48 hours postoperatively, expressed as oral morphine equivalents (mg OME). Only sufentanil delivered by the patient-controlled intravenous analgesia device is counted and is converted to OME using standard equianalgesic conversion tables. Intravenous flurbiprofen axetil given as rescue analgesia is a non-opioid and is not counted. Any additional opioid administered during or after surgery is converted and included in the total. | |
Papers
PubMed papers this trial cites; 3 papers, results papers first, then newest first.
Lead sponsor's other trials
Beijing Tsinghua Chang Gung Hospital, most recent start first.
+104 more trials See the organization page
Similar trials
Same condition (Kidney Calculi) and phase, most recent start first.
+301 more trials See the condition page